-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/scope-communicating-evolving-evidence-white-paper.pdf
July 01, 2023 - Prescription
Opioid Taper Support for Reduction of Pain and
Opioid Dose in Patients with Chronic Non-Cancer
-
effectivehealthcare.ahrq.gov/products/prostatic-hyperplasia-medications/research-protocol
April 24, 2015 - Consensus recommendations from the 6th International Consultation on New Developments in Prostate Cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-protein-intake-protocol-amendment.pdf
November 29, 2023 - muscle mass plays an important role in the most
common chronic conditions (such as heart disease and cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-epilepsy-amended-protocol.pdf
March 07, 2021 - The fate of abstracts submitted to a cancer
meeting: factors which influence presentation
and subsequent
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/wic-outcomes-nutrition-protocol-amended.pdf
October 01, 2020 - J Natl Cancer Inst. 1959 Apr;22(4):719-48.
13. Noyes J, Booth A, Cargo M, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/scope-communicating-evolving-evidence-white-paper_0.pdf
August 01, 2024 - Prescription
Opioid Taper Support for Reduction of Pain and
Opioid Dose in Patients with Chronic Non-Cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
January 01, 2010 - flexible, transabdominal via colostomy, single
or multiple), an HCPCS code (e.g., G0105
Colorectal cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicide-prevention_disposition-comments.pdf
October 04, 2016 - study
suicide prevention is that different that of bringing together
health system data to study cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-nonpharmacologic-treatment_research-protocol.pdf
October 04, 2016 - The fate of abstracts submitted to a cancer meeting: factors
which influence presentation and subsequent
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis_research-protocol.pdf
June 06, 2011 - disease in women has
exceeded that in men, reaching 454,613 in 2005, more than deaths from all forms of
cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendicitis_executive.pdf
December 01, 2015 - definitive
diagnosis is sometimes delayed further because competing
etiologies for abdominal pain (e.g., malignancy … near term, one had a premature delivery
of a live 30-week infant 3 days after CT-diagnosed
gastric cancer … Cancer risks from diagnostic radiology.
Br J Radiol. 2008 May;81(965):362-78. PMID: 18440940.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
January 01, 2020 - Oral
bisphosphonates and risk of cancer of
oesophagus, stomach, and colorectum: case-
control analysis … of
osteomalacia; Paget’s disease;
Osteogenesis imperfecta;
Gastrointestinal disease;
History of malignancy … exhibiting
shortness of breath or chest
pain
Any medical condition that
might affect BMD (e.g., bone
cancer
-
effectivehealthcare.ahrq.gov/health-topics/malnutrition
October 30, 2020 - Malnutrition in Hospitalized Adults
Research Protocol
October 30, 2020
-
effectivehealthcare.ahrq.gov/products/calcineurin-inhibitor/research-protocol
October 14, 2014 - threshold and how measured
New onset diabetes after transplant
Major adverse cardiac events
Malignancy … The fate of abstracts submitted to a cancer meeting: factors which influence presentation and subsequent
-
effectivehealthcare.ahrq.gov/health-topics/sexual-health
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - commercially since 2000 in a leuprolide acetate implant (Viadur®) for treating advanced prostate
cancer … Standard bariatric surgery has suggested fewer cardiovascular events and possibly fewer
cancers in … Bevacizumab (Avastin®) and
pegaptanib (Macugen®) are anti-VEGF (antiangiogenic) drugs typically used in cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
October 08, 2014 - threshold and how measured
§ New onset diabetes after transplant
§ Major adverse cardiac events
§ Malignancy … Nephrotoxicity
• New onset diabetes
• Major cardiac events
• Neurologic complications
• Infections
• Malignancy … The fate of abstracts submitted to a cancer
meeting: factors which influence presentation
and subsequent
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
October 01, 2015 - patient acceptance.60 Payers are likely to cover both drugs
because IPF has a worse prognosis than some cancers … estimated to cost about $40,000 annually at the time of expert comment, which is less than many
cancer
-
effectivehealthcare.ahrq.gov/health-topics/antioxidants
-
effectivehealthcare.ahrq.gov/health-topics/quitting-smoking/